Published in J Neuropathol Exp Neurol on September 01, 1994
Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46
Propagating structure of Alzheimer's beta-amyloid(10-35) is parallel beta-sheet with residues in exact register. Proc Natl Acad Sci U S A (1998) 3.74
Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40
Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol (1998) 2.85
Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci U S A (1995) 2.53
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A (2002) 1.87
Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med (1998) 1.84
Molecular basis for amyloid-beta polymorphism. Proc Natl Acad Sci U S A (2011) 1.76
Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J (2012) 1.70
Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry (1998) 1.62
Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol (1995) 1.53
Atomic-resolution structure of a disease-relevant Aβ(1-42) amyloid fibril. Proc Natl Acad Sci U S A (2016) 1.51
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J Cell Mol Med (2008) 1.48
Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. Biophys J (2001) 1.45
Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research. Nat Protoc (2010) 1.40
Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Abeta species in amyloid precursor protein transgenic mice. J Neurosci (2007) 1.31
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomers. J Biol Chem (2007) 1.30
The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br J Pharmacol (2006) 1.29
In situ characterization of beta-amyloid in Alzheimer's diseased tissue by synchrotron Fourier transform infrared microspectroscopy. Biophys J (1996) 1.25
Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease. Am J Pathol (1998) 1.21
Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci (2009) 1.19
Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol (2004) 1.16
Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study. J Neurol Neurosurg Psychiatry (2010) 1.13
Rosiglitazone rescues memory impairment in Alzheimer's transgenic mice: mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology (2010) 1.12
Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene. J Clin Invest (1996) 1.09
Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch. Vaccine (2005) 1.09
Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575. Mol Neurodegener (2009) 1.07
Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide. Biophys J (2001) 1.06
Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.06
Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease. ACS Chem Neurosci (2013) 1.05
Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. Proc Natl Acad Sci U S A (1999) 1.05
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J Neurosci (2013) 1.02
Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention. CNS Neurol Disord Drug Targets (2010) 1.02
Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. J Mol Biol (2008) 1.01
Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol (2009) 0.99
Assembly and kinetic folding pathways of a tetrameric beta-sheet complex: molecular dynamics simulations on simplified off-lattice protein models. Biophys J (2004) 0.99
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease. J Neurosci (2009) 0.98
Role of synucleins in Alzheimer's disease. Neurotox Res (2009) 0.98
Phase behavior of an intact monoclonal antibody. Biophys J (2007) 0.97
Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice. J Neuroinflammation (2008) 0.97
Dynamics of plaque formation in Alzheimer's disease. Biophys J (1999) 0.96
Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathol (2011) 0.96
Abeta oligomers and fibrillar aggregates induce different apoptotic pathways in LAN5 neuroblastoma cell cultures. Biophys J (2009) 0.93
Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology. Cell Death Differ (2012) 0.93
Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice. Neurobiol Aging (2009) 0.91
Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin Exp Immunol (1999) 0.91
Membrane localization of beta-amyloid 1-42 in lysosomes: a possible mechanism for lysosome labilization. J Biol Chem (2010) 0.91
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease. Alzheimers Res Ther (2010) 0.91
SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination. Proc Natl Acad Sci U S A (2014) 0.90
Crosstalk between Cdk5 and GSK3beta: Implications for Alzheimer's Disease. Front Mol Neurosci (2009) 0.89
Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis (2012) 0.89
Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy. CNS Neurol Disord Drug Targets (2009) 0.89
Protective effects of the sigma agonist Pre-084 in the rat retina. Br J Ophthalmol (2007) 0.89
Effects of S-2474, a novel nonsteroidal anti-inflammatory drug, on amyloid beta protein-induced neuronal cell death. Br J Pharmacol (2001) 0.89
TNF-related apoptosis-inducing ligand level in Alzheimer's disease. Neurol Sci (2009) 0.88
Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease. Int J Biol Sci (2014) 0.88
Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. PLoS One (2007) 0.87
Thermodynamics and stability of a beta-sheet complex: molecular dynamics simulations on simplified off-lattice protein models. Protein Sci (2004) 0.86
Increased expression of β amyloid precursor gene in the hippocampus of streptozotocin-induced diabetic mice with memory deficit and anxiety induction. J Neural Transm (Vienna) (2010) 0.84
Folding thermodynamics of model four-strand antiparallel beta-sheet proteins. Biophys J (2002) 0.84
Inhibitory Effects of Eucommia ulmoides Oliv. Bark on Scopolamine-Induced Learning and Memory Deficits in Mice. Biomol Ther (Seoul) (2013) 0.84
Transmembrane fragment structures of amyloid precursor protein depend on membrane surface curvature. J Am Chem Soc (2014) 0.84
Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia. Curr Neuropharmacol (2006) 0.83
Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease. Exp Neurol (2014) 0.82
Observation of liquid-liquid phase separation for eye lens gammaS-crystallin. Proc Natl Acad Sci U S A (2003) 0.82
Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity. ACS Chem Neurosci (2013) 0.82
Sodium dodecyl sulfate-resistant complexes of Alzheimer's amyloid beta-peptide with the N-terminal, receptor binding domain of apolipoprotein E. Biophys J (2000) 0.81
Attenuation of beta-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment. Brain Res (2007) 0.81
Protein folding pathways and kinetics: molecular dynamics simulations of beta-strand motifs. Biophys J (2002) 0.81
Benchmarking implicit solvent folding simulations of the amyloid beta(10-35) fragment. J Phys Chem B (2008) 0.80
Axonal and Schwann cell BACE1 is equally required for remyelination of peripheral nerves. J Neurosci (2015) 0.80
Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med J (2014) 0.80
Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases. Neurochem Res (2013) 0.79
Early onset Alzheimer's disease and oxidative stress. Oxid Med Cell Longev (2014) 0.79
Potential role of estrogen in the pathobiology and prevention of Alzheimer's disease. Am J Transl Res (2009) 0.79
Protective role of caffeic acid in an Aβ25-35-induced Alzheimer's disease model. Nutr Res Pract (2015) 0.79
Neuroprotective and neurorescuing effects of isoform-specific nitric oxide synthase inhibitors, nitric oxide scavenger, and antioxidant against beta-amyloid toxicity. Br J Pharmacol (2001) 0.79
Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease. Acta Neuropathol (2015) 0.79
Apolipoprotein E, A beta, and Alzheimer disease. J Neuropathol Exp Neurol (1994) 0.79
Kinetic study of beta-amyloid residue accessibility using reductive alkylation and mass spectrometry. Biotechnol Bioeng (2009) 0.78
Simvastatin enhances immune responses to Aβ vaccination and attenuates vaccination-induced behavioral alterations. Brain Res (2010) 0.78
Optimized turmeric extract reduces β-Amyloid and phosphorylated Tau protein burden in Alzheimer's transgenic mice. Curr Alzheimer Res (2012) 0.78
Down's syndrome and the links with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1995) 0.78
Reversal of aggregation using β-breaker dipeptide containing peptides: Application to Aβ(1-40) self-assembly and its inhibition. ACS Chem Neurosci (2014) 0.78
The age related amyloids: a growing family of unique biochemical substances. J Clin Pathol (1995) 0.78
1-42 β-amyloid peptide requires PDK1/nPKC/Rac 1 pathway to induce neuronal death. Transl Psychiatry (2013) 0.77
Molecular neuropathogenesis of Alzheimer's disease: an interaction model stressing the central role of oxidative stress. Future Neurol (2012) 0.77
Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules. Sci Rep (2016) 0.77
Use of a combination of the RDC method and NOESY NMR spectroscopy to determine the structure of Alzheimer's amyloid Aβ10-35 peptide in solution and in SDS micelles. Eur Biophys J (2013) 0.77
17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. J Neural Transm (Vienna) (2008) 0.77
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease. Front Neurosci (2016) 0.77
Circulating biomarkers that predict incident dementia. Alzheimers Res Ther (2014) 0.77
The genetics of Alzheimer's disease. Scientifica (Cairo) (2012) 0.76
Association of skin with the pathogenesis and treatment of neurodegenerative amyloidosis. Front Neurol (2012) 0.76
Transgenic rice expressing amyloid β-peptide for oral immunization. Int J Biol Sci (2011) 0.76
Chaperone-like antibodies in neurodegenerative tauopathies: implication for immunotherapy. Cell Mol Neurobiol (2009) 0.76
Alzheimer's disease and prion proteins: a meeting made in muscle. Am J Pathol (1994) 0.76
Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments. J Neurol (2016) 0.76
The molecular pathology of Alzheimer's disease. Neuron (1991) 8.21
Amyloid beta protein precursor and the pathogenesis of Alzheimer's disease. Cell (1989) 1.31
Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease. Curr Opin Neurobiol (1994) 0.98
Molecular relation of amyloid filaments and paired helical filaments in Alzheimer's disease. Adv Neurol (1990) 0.76